UnitedHealth Group Incorporated $UNH Shares Bought by Premier Path Wealth Partners LLC

Premier Path Wealth Partners LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 32.1% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 7,830 shares of the healthcare conglomerate’s stock after purchasing an additional 1,902 shares during the period. Premier Path Wealth Partners LLC’s holdings in UnitedHealth Group were worth $3,254,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the business. Brighton Jones LLC lifted its holdings in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares during the period. Revolve Wealth Partners LLC lifted its stake in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares during the period. CMT Capital Markets Trading GmbH purchased a new stake in UnitedHealth Group during the second quarter worth about $340,000. Flow Traders U.S. LLC acquired a new stake in shares of UnitedHealth Group during the 2nd quarter valued at approximately $356,000. Finally, Jump Financial LLC acquired a new position in UnitedHealth Group during the second quarter worth $377,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the company. JPMorgan Chase & Co. raised their price target on UnitedHealth Group from $466.00 to $516.00 and gave the company an “overweight” rating in a research report on Tuesday, July 21st. UBS Group increased their price objective on shares of UnitedHealth Group from $460.00 to $490.00 and gave the company a “buy” rating in a research note on Friday, July 17th. Zacks Research raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th. Sanford C. Bernstein reissued an “outperform” rating on shares of UnitedHealth Group in a research note on Wednesday. Finally, KeyCorp upped their target price on UnitedHealth Group from $400.00 to $475.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $456.56.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $401.05 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.78. The company has a market cap of $359.98 billion, a PE ratio of 25.81, a price-to-earnings-growth ratio of 1.50 and a beta of 0.61. The company has a 50-day simple moving average of $412.27 and a 200-day simple moving average of $363.93. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. During the same quarter last year, the business earned $4.08 earnings per share. UnitedHealth Group’s revenue was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be paid a $2.32 dividend. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date of this dividend is Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 59.72%.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth is showing operational improvement: medical-cost pressure appears to be easing, Optum is gaining momentum and management has raised its 2026 earnings outlook. These developments support the case for a sustained earnings recovery. Is UnitedHealth Finally Turning the Corner After a Tough 2025?
• Positive Sentiment: UnitedHealthcare plans to remove prior-authorization requirements for roughly 30% of approvals beginning October 1 across several treatment and testing categories. The move could improve member and provider relations while reducing administrative friction, without abandoning cost controls. UnitedHealth Rises as 30% of Prior Approvals Head for Removal
• Positive Sentiment: Potentially higher employer healthcare costs may create additional demand for UnitedHealth’s cost-management and healthcare solutions. Healthcare is also being viewed as a defensive sector amid September concerns about oil prices, interest rates and employment. How Can Healthcare Inflation Fuel Growth for MRSH, UNH and CNC?
• Neutral Sentiment: Wall Street’s average recommendation remains equivalent to Buy, but the usefulness of that signal is limited because analyst ratings can be overly optimistic. Brokers Suggest Investing in UnitedHealth
• Negative Sentiment: UNH has gained about 41% since early March, and some analysts argue the share price already reflects much of the turnaround. Margins have not recovered as fully as the stock, raising the risk of disappointment if earnings improvement slows. UnitedHealth Stock Recovered Before Its Margins Did

Insider Buying and Selling

In other news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This represents a 7.09% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.19% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.